# LivaNova says new oxygenator production line is operating

_Published Monday, November 9, 2026 at 2:18 PM EST · Products · Latest · Tier 2 — Notable_

![The Globe and Mail — Primary](https://www.theglobeandmail.com/pf/resources/assets/meta/twitter-summary-240x240.png?d=988)

LivaNova said during its third-quarter earnings call that its dedicated oxygenator manufacturing line is operating and production has begun. The company is building inventory and expects the line to contribute financially next year. Oxygenators are used in its cardiopulmonary business.

Management expects double-digit capacity and output growth in 2027, with an agreement with Thermo Fisher supporting further expansion. Better availability of third-party components and internal manufacturing improvements have already increased oxygenator output year over year. Demand continues to exceed supply, leaving a backlog. Capital spending reached $77 million during the first nine months of 2026, compared with $49 million a year earlier, supporting manufacturing, digital health and information technology investments.

## Sources

- [The Globe and Mail](https://www.theglobeandmail.com/investing/markets/stocks/LIVN/pressreleases/8688999/livanova-earnings-call-signals-strong-growth-ahead/)

---
Canonical: https://techandbusiness.org/newswire/CKFVmg8OVjzAl9zJbiBdMe
Published: 2026-11-09T19:18:13.786Z
Story chronology: 2026-11-09T19:01:00.000Z
Retrieved: 2026-11-09T21:41:36.921Z
Publisher: Tech & Business (techandbusiness.org)